Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 25;11(4):491.
doi: 10.3390/biom11040491.

Infarct in the Heart: What's MMP-9 Got to Do with It?

Affiliations
Review

Infarct in the Heart: What's MMP-9 Got to Do with It?

Mediha Becirovic-Agic et al. Biomolecules. .

Abstract

Over the past three decades, numerous studies have shown a strong connection between matrix metalloproteinase 9 (MMP-9) levels and myocardial infarction (MI) mortality and left ventricle remodeling and dysfunction. Despite this fact, clinical trials using MMP-9 inhibitors have been disappointing. This review focuses on the roles of MMP-9 in MI wound healing. Infiltrating leukocytes, cardiomyocytes, fibroblasts, and endothelial cells secrete MMP-9 during all phases of cardiac repair. MMP-9 both exacerbates the inflammatory response and aids in inflammation resolution by stimulating the pro-inflammatory to reparative cell transition. In addition, MMP-9 has a dual effect on neovascularization and prevents an overly stiff scar. Here, we review the complex role of MMP-9 in cardiac wound healing, and highlight the importance of targeting MMP-9 only for its detrimental actions. Therefore, delineating signaling pathways downstream of MMP-9 is critical.

Keywords: extracellular matrix; inflammation; macrophage; matrix metalloproteinases; neutrophil; remodeling.

PubMed Disclaimer

Conflict of interest statement

All authors have read the journal authorship agreement and policy on disclosure of potential conflicts of interest and have nothing to disclose.

Figures

Figure 1
Figure 1
Temporal profile of MMP-9, leukocytes, and fibroblasts during myocardial infarction wound healing. The left side shows the temporal profile of MMP-9 and the relative abundance of neutrophils, macrophages, B-cells, T-cells, and fibroblasts during inflammation, proliferation and maturation phase. The graphs are based on the current literature [77,78,79,80,81,82,83,84]. The right side shows the cellular source of MMP-9, as well as in vitro stimulators of MMP-9 release and the effect of MMP-9 on different myocardial infarction wound healing processes. IL-1β: Interleukin 1 beta, IL-8: Interleukin 8, MMP-9: Matrix metalloproteinase-9, TNFα: Tumor necrosis alpha, N1: Pro-inflammatory neutrophils, N2: Anti-inflammatory/reparative neutrophils, M1: Pro-inflammatory macrophages, M2: Anti-inflammatory/reparative macrophages, F1: Pro-inflammatory fibroblasts, F2: Anti-inflammatory/reparative fibroblasts. Created with BioRender.com (accessed on 23 March 2021) [85].
Figure 2
Figure 2
MMP-9 roles in inflammation and resolution after myocardial infarction. DAMPs: Danger associated molecular patterns, CD36: Cluster of differentiation 36, CXCL: CXC motif ligand, IL-1β: Interleukin 1 beta, IL-8: Interleukin 8, MMP: Matrix metalloproteinase, PTM: Post-translational modification, TIMP: Tissue inhibitor of metalloproteinases, TGFβ: Transforming growth factor beta. M1: Pro-inflammatory macrophages, M2: Anti-inflammatory/reparative macrophages, F1: Pro-inflammatory fibroblasts, F2: Anti-inflammatory/reparative fibroblasts. Created with BioRender.com (accessed on 23 March 2021) [85].

Similar articles

Cited by

References

    1. Prabhu S.D., Frangogiannis N.G. The Biological Basis for Cardiac Repair after Myocardial Infarction: From Inflammation to Fibrosis. Circ. Res. 2016;119:91–112. doi: 10.1161/CIRCRESAHA.116.303577. - DOI - PMC - PubMed
    1. Ferrini A., Stevens M.M., Sattler S., Rosenthal N. Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation. Front. Cardiovasc. Med. 2019;6:26. doi: 10.3389/fcvm.2019.00026. - DOI - PMC - PubMed
    1. Kloner R.A., Brown D.A., Csete M., Dai W., Downey J.M., Gottlieb R.A., Hale S.L., Shi J. New and revisited approaches to preserving the reperfused myocardium. Nat. Rev. Cardiol. 2017;14:679–693. doi: 10.1038/nrcardio.2017.102. - DOI - PMC - PubMed
    1. Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics-2020 Update: A Report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. - DOI - PubMed
    1. Clarke S.A., Richardson W.J., Holmes J.W. Modifying the mechanics of healing infarcts: Is better the enemy of good? J. Mol. Cell. Cardiol. 2016;93:115–124. doi: 10.1016/j.yjmcc.2015.11.028. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources